Delivery Order SPE2DB20D7066-SPE2DB26FC1NF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of 500 tablets of Mirtazapine 7.5 mg, a generic antidepressant medication commonly used in military and veteran healthcare systems. This competitively awarded, non-set-aside contract is valued at $2,556.45 with a firm fixed price structure and a completion date of September 23, 2025. The award is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 500 units, valued at $5,732.50 under a firm fixed-price contract. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 500 units, with a ceiling value of $4,537.30. This firm fixed price delivery order, with an ultimate completion date of April 25, 2025, represents a non-competitive award and will be performed at the contractor's Conshohocken, Pennsylvania location. The order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of 1,000 units of Mirtazapine 15mg tablets, with a contract ceiling value of $3,121.88. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $1,107.52 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of 500 tablets of Mirtazapine 7.5 mg. This is a non-set-aside, firm fixed-price delivery order with an ultimate completion date of September 30, 2025, performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order under an unspecified contract vehicle to Amerisourcebergen Drug Corporation to provide 30 tablets of the generic antidepressant Mirtazapine at 7.5 mg per tablet. Valued at $958.09, this firm fixed price order calls for delivery to a facility in Conshohocken, Pennsylvania between September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide...
- The Defense Logistics Agency awarded a $2,402.57 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Mirtazapine 15 mg, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 16, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 30 per unit. The contract, which is a non-set-aside, competitively awarded delivery order with firm fixed pricing, carries a ceiling value of $1,149.60 and an ultimate completion date of June 17, 2025. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-four thousand seven hundred dollars and seventy cents ($144,700) to Amerisourcebergen Drug Corporation for the supply of one thousand (1,000) packages of fifteen (15) milligram Mirtazapine tablets. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 31, 2023 to fulfill requirements under the Agency's pharmaceutical supply vehicle. As a top provider...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,216.91 and an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1NFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of 1,000 tablets of Mirtazapine 30 mg, a generic antidepressant medication commonly used in military and veteran healthcare settings. This non-competitive delivery order, valued at $3,425.77 with firm fixed pricing, is scheduled for completion by November 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement transaction within the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's standing as a prime contractor under this comprehensive vehicle demonstrates its capability to fulfill ongoing pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 11/3/25 |